Man Utd boss Ruben Amorim is keen to work with Chelsea forward Christopher Nkunku and is willing to offer Alejandro Garnacho ...

Fresh tariffs amid high inflation are making the Fed’s job uniquely difficult and feeding uncertainty about what to expect ...

Despite asserting that he wants to keep Alejandro Garnacho, Ruben Amorim is keen to work with Christopher Nkunku, according ...

Despite joining RB Leipzig permanently in a blockbuster deal, Xavi Simons could be on his way out in the summer.

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Man Utd's interest in Mathys Tel appears to have been short-lived as Bayern Munich have agreed a €60 million deal with ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

Chelsea are readying a new approach for Manchester United winger Alejandro Garnacho, according to a report. The last few days ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...